Today's Wall Street Journal features Sproxil's partnership with the National Agency for Food and Drug Administration and Control (Nigeria's FDA) and one of Nigeria's largest drug companies, BIOFEM Pharmaceuticals to deliver extra value to consumers in Nigeria in the fight against counterfeits.